ALS Investment Fund Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
14
- Portfolio
-
8
- Exits
-
3
ALS Investment Fund General Information
Company Description
Founded in 2016, ALS Investment Fund is a venture capital firm based in Amsterdam, Netherlands. The firm seeks to invest in the biotechnology sector, with a focus on disease-modifying therapies for neurodegenerative diseases / ALS.
Business Details
Website
www.alsinvestmentfund.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Amsterdam
- Netherlands
ALS Investment Fund Investments (14)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| VectorY Therapeutics | 11-Nov-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Bloom Science | 13-Nov-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| ProJenX | 18-Mar-2024 | Drug Discovery | Clinical Trials - General | |||
| VectorY Therapeutics | 13-Nov-2023 | Drug Discovery | Clinical Trials - Phase 1 | |||
| QurAlis | 09-Mar-2023 | Therapeutic Devices | Clinical Trials - Phase 1 | |||
| Prilenia | 12-Apr-2022 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Verge Labs | 15-Dec-2021 | Drug Discovery | Generating Revenue | |||
| Bloom Science | 09-Dec-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Apic Bio | 11-Nov-2020 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Prilenia | 03-Jun-2020 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 3 |
ALS Investment Fund Exits (3)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Amylyx Pharmaceuticals | 07-Oct-2022 | Public Investment 2nd Offering | |
| Amylyx Pharmaceuticals | 07-Jan-2022 | ||
| Strategic Partners (Denmark) | 21-Nov-2017 |
ALS Investment Fund Investments by Industry, Year, and Region
ALS Investment Fund Co-Investors (31)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| EQT Life Sciences | 2 |
|
|
||
| Forbion |
|
|
|||
| SV Health Investors |
|
|
|||
| Amgen Ventures |
|
|
|||
| Insight Partners (New York) |
|
|
ALS Investment Fund FAQs
-
What is ALS Investment Fund?
Founded in 2016, ALS Investment Fund is a venture capital firm based in Amsterdam, Netherlands.
-
When was ALS Investment Fund founded?
ALS Investment Fund was founded in 2016.
-
Where is ALS Investment Fund headquartered?
ALS Investment Fund is headquartered in Amsterdam, Netherlands.
-
What is ALS Investment Fund's total asset value?
ALS Investment Fund has around in total assets under management.
-
How many investments has ALS Investment Fund made?
ALS Investment Fund has made 14 investments.
-
What has ALS Investment Fund invested in?
ALS Investment Fund has made numerous investments in companies like VectorY Therapeutics, Bloom Science, and ProJenX within the Drug Discovery industry.
-
What has ALS Investment Fund invested in recently?
ALS Investment Fund's latest investment was on 11-Nov-2026 in VectorY Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process